Aclarion Added To PRISM Emerging Medical Devices Index, Co's Technology Addresses Chronic Low Back Pain; Aclarion Secured Its First Commercial Agreement With Michigan's Sheridan Community Hospital

Author: Benzinga Newsdesk | September 06, 2024 11:29am

• Company's industry-first technology addresses chronic low back pain
• Aclarion secured its first commercial agreement with Michigan's Sheridan Community Hospital
  
   
• PRISM Emerging Medical Devices Index features companies at forefront of innovation and market disruption in medtech
  
   

NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView, a leading provider of market insights and company news, is excited to announce that Aclarion, Inc. (NASDAQ:ACON) has been added to the PRISM Emerging Medical Devices Index, which highlights companies at the forefront of innovation and market disruption in the medtech sector. Aclarion's innovative AI-driven diagnostic solutions for chronic low back pain position the company as a standout in the evolving medical devices sector.

The U.S. medical devices market is projected to grow significantly, reaching an estimated value of nearly $315 billion by 2032. This expansion is driven by increasing R&D investments and a robust pipeline of innovations, including Aclarion's NOCISCAN technology, which offers the first noninvasive, AI-supported diagnostic tool for identifying painful discs in patients suffering from chronic low back pain.

Posted In: ACON